This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Jinhua Shouxiangu Pharmaceutical Co. Ltd, Zhejiang Shouxiangu Pharmaceutical Company, Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Huaxian Zheng: Innovator in Pharmaceutical Technology
Introduction
Huaxian Zheng is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceutical technology, particularly through his innovative patent related to ganoderma lucidum spores. His work focuses on enhancing the efficacy and absorption of active components in medicinal tablets.
Latest Patents
Huaxian Zheng holds a patent for a "Tablet of sporoderm-removed ganoderma lucidum spore and preparation method thereof." This invention provides a tablet that includes an aqueous extract of sporoderm-disrupted spore powder, sorbitol, and povidone K30. The preparation method involves mixing these components, granulating, screening, and drying to create a granular material, which is then tableted. This tablet is designed to enhance body immunity and has anti-radiation and anti-tumor effects, making it a convenient dosage form for users.
Career Highlights
Throughout his career, Huaxian Zheng has worked with reputable companies in the pharmaceutical industry, including Zhejiang Shouxiangu Pharmaceutical Company, Ltd. and Jinhua Shouxiangu Pharmaceutical Co. Ltd. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical products.
Collaborations
Huaxian Zheng has collaborated with notable colleagues such as Zhenhao Li and Mingyan Li. Their teamwork has played a crucial role in advancing their shared goals in pharmaceutical innovation.
Conclusion
Huaxian Zheng's contributions to the field of pharmaceutical technology, particularly through his innovative patent, demonstrate his commitment to enhancing health solutions. His work continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile